Recent progress in immunotherapy: anti-cancer vaccines, emerging clinical data

被引：1
作者：
Dalgleish, A. G. [1 ]
机构：
[1] St Georges Univ London, Dept Cellular & Mol Med, London, England
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
10.1093/annonc/mdn441
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：248 / 251
页数：4
相关论文
共 20 条
  • [1] Antiandrogen, vaccine and combination therapy in patients with nonmetastatic hormone refractory prostate cancer
    Arlen, PM
    Gulley, JL
    Todd, N
    Lieberman, R
    Steinberg, SM
    Morin, S
    Bastian, A
    Marte, J
    Tsang, KY
    Beetham, P
    Grosenbach, DW
    Schlom, J
    Dahut, W
    [J]. JOURNAL OF UROLOGY, 2005, 174 (02) : 539 - 546
  • [2] COPIER J, 2007, VACCINE IN PRESS
  • [3] Review article: immune suppression and colorectal cancer
    Evans, C.
    Dalgleish, A. G.
    Kumar, D.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (08) : 1163 - 1177
  • [4] Lessons from randomized phase III studies with active cancer immunotherapies - Outcomes from the 2006 Meeting of the Cancer Vaccine Consortium (CVC)
    Finke, Lothar H.
    Wentworth, Kerry
    Blumenstein, Brent
    Rudolph, Natalie S.
    Levitsky, Hyarn
    Hoos, Axel
    [J]. VACCINE, 2007, 25 : B97 - B109
  • [5] Enhancing efficacy of therapeutic vaccinations by combination with other modalities
    Gulley, James L.
    Madan, Ravi A.
    Arlen, Philip M.
    [J]. VACCINE, 2007, 25 : B89 - B96
  • [6] Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection
    Heriot, AG
    Marriott, JB
    Cookson, S
    Kumar, D
    Dalgleish, AG
    [J]. BRITISH JOURNAL OF CANCER, 2000, 82 (05) : 1009 - 1012
  • [7] Allogeneic whole-tumour cell vaccination in the rat model of prostate cancer
    Hrouda, D
    Todryk, SM
    Perry, MJA
    Souberbielle, BE
    Kayaga, J
    Kirby, RS
    Dalgleish, AG
    [J]. BJU INTERNATIONAL, 2000, 86 (06) : 742 - 748
  • [8] Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine
    Hsueh, EC
    Essner, R
    Foshag, LJ
    Ollila, DW
    Gammon, G
    O'Day, SJ
    Boasberg, PD
    Stern, SL
    Ye, X
    Morton, DL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (23) : 4549 - 4554
  • [9] Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial
    Jocham, D
    Richter, A
    Hoffmann, L
    Iwig, K
    Fahlenkamp, D
    Zakrzewski, G
    Schmitt, E
    Dannenberg, T
    Lehmacher, W
    von Wietersheim, J
    Doehn, C
    [J]. LANCET, 2004, 363 (9409) : 594 - 599
  • [10] Lee KH, 1998, J IMMUNOL, V161, P4183
12